By using this website, you agree to the storing of cookies on your device. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy.

Press Release

Slingshot Biosciences Welcomes Visionary Leader and Industry Expert Dr. Nimisha Srivastava as new Chief Operations Officer

Press Release

Tiffany Salas-Morris Joins Slingshot Biosciences as Chief Commercial Officer

Event

Cell Therapy Analytical Development Summit 2024

December 3, 2024
Press Release

Prolocor and Slingshot Biosciences Announce Publication of ‘Assessing Prognosis by Quantifying FcγRIIa on Fixed Platelets’ in Bioanalysis

Event

CAR TCR 2024

September 17, 2024
Event

BioProcessing Summit 2024

August 19, 2024
News

Inside Slingshot Biosciences’ On-Demand Synthetic Cell Platform

Press Release

Slingshot Biosciences Unveils a Novel Cell Therapy-Focused Portfolio to Streamline Development while Improving Manufacturing and Clinical Trial Capabilities

Press Release

Slingshot Biosciences Announces Election of Nicolas Barthelemy as Executive Chair

Press Release

Slingshot Biosciences Announces $11 Million in Series A3 Financing

Press Release

Slingshot Biosciences, Inc. Partners With Palex Medical to Distribute Synthetic Cells Throughout Spain and Portugal

Press Release

Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France

Press Release

Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland

Press Release

Slingshot Biosciences, Inc. Partners With Cambridge Bioscience to Distribute Synthetic Cells Throughout United Kingdom and Ireland

Press Release

Slingshot Biosciences, Inc. Partners With Almog Diagnostic To Distribute Synthetilc Cells Throughout Israel

Press Release

Slingshot Biosciences Announces $23 Million in Series A Financing